97 related articles for article (PubMed ID: 32182088)
61. Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus.
Song SY; Choi W; Shin SS; Lee SW; Ahn SD; Kim JH; Je HU; Park CI; Lee JS; Choi EK
Lung Cancer; 2009 Oct; 66(1):89-93. PubMed ID: 19168260
[TBL] [Abstract][Full Text] [Related]
62. Stereotactic body radiation therapy for isolated hilar and mediastinal non-small cell lung cancers.
Horne ZD; Richman AH; Dohopolski MJ; Clump DA; Burton SA; Heron DE
Lung Cancer; 2018 Jan; 115():1-4. PubMed ID: 29290248
[TBL] [Abstract][Full Text] [Related]
63. Tumor Control and Toxicity after SBRT for Ultracentral, Central, and Paramediastinal Lung Tumors.
Nguyen KNB; Hause DJ; Novak J; Monjazeb AM; Daly ME
Pract Radiat Oncol; 2019 Mar; 9(2):e196-e202. PubMed ID: 30496842
[TBL] [Abstract][Full Text] [Related]
64. Stereotactic body radiation therapy for locally advanced and borderline resectable pancreatic cancer is effective and well tolerated.
Chuong MD; Springett GM; Freilich JM; Park CK; Weber JM; Mellon EA; Hodul PJ; Malafa MP; Meredith KL; Hoffe SE; Shridhar R
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):516-22. PubMed ID: 23562768
[TBL] [Abstract][Full Text] [Related]
65. Hypo-fractionated stereotactic radiation therapy for lung malignancies by means of helical tomotherapy: report of feasibility by a single-center experience.
Figlia V; Mazzola R; Cuccia F; Alongi F; Mortellaro G; Cespuglio D; Cucchiara T; Iacoviello G; Valenti V; Molino M; Verderame F; Matranga D; Casto AL; Ferrera G
Radiol Med; 2018 Jun; 123(6):406-414. PubMed ID: 29455424
[TBL] [Abstract][Full Text] [Related]
66. Stereotactic, single-dose irradiation of stage I non-small cell lung cancer and lung metastases.
Fritz P; Kraus HJ; Mühlnickel W; Hammer U; Dölken W; Engel-Riedel W; Chemaissani A; Stoelben E
Radiat Oncol; 2006 Aug; 1():30. PubMed ID: 16919172
[TBL] [Abstract][Full Text] [Related]
67. Results of high-dose thoracic irradiation incorporating beam's eye view display in non-small cell lung cancer: a retrospective multivariate analysis.
Hazuka MB; Turrisi AT; Lutz ST; Martel MK; Ten Haken RK; Strawderman M; Borema PL; Lichter AS
Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):273-84. PubMed ID: 8407401
[TBL] [Abstract][Full Text] [Related]
68. A phase I/II study on stereotactic body radiotherapy with real-time tumor tracking using CyberKnife based on the Monte Carlo algorithm for lung tumors.
Iwata H; Ishikura S; Murai T; Iwabuchi M; Inoue M; Tatewaki K; Ohta S; Yokota N; Shibamoto Y
Int J Clin Oncol; 2017 Aug; 22(4):706-714. PubMed ID: 28429140
[TBL] [Abstract][Full Text] [Related]
69. CyberKnife frameless single-fraction stereotactic radiosurgery for tumors of the sacrum.
Gerszten PC; Ozhasoglu C; Burton SA; Welch WC; Vogel WJ; Atkins BA; Kalnicki S
Neurosurg Focus; 2003 Aug; 15(2):E7. PubMed ID: 15350038
[TBL] [Abstract][Full Text] [Related]
70. Conformal high dose external radiation therapy, 80.5 Gy, alone for medically inoperable non-small cell lung cancer: a retrospective analysis.
Urbanic JJ; Turrisi AT; Sharma AK; Silvestri GA; Williams TE; Vanek KN; Sherman CA
J Thorac Oncol; 2006 Feb; 1(2):112-9. PubMed ID: 17409839
[TBL] [Abstract][Full Text] [Related]
71. Stereotactic body radiation therapy in recurrent hepatocellular carcinoma.
Huang WY; Jen YM; Lee MS; Chang LP; Chen CM; Ko KH; Lin KT; Lin JC; Chao HL; Lin CS; Su YF; Fan CY; Chang YW
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):355-61. PubMed ID: 22342300
[TBL] [Abstract][Full Text] [Related]
72. Phase 2 Study of Stereotactic Body Radiation Therapy and Stereotactic Body Proton Therapy for High-Risk, Medically Inoperable, Early-Stage Non-Small Cell Lung Cancer.
Nantavithya C; Gomez DR; Wei X; Komaki R; Liao Z; Lin SH; Jeter M; Nguyen QN; Li H; Zhang X; Poenisch F; Zhu XR; Balter PA; Feng L; Choi NC; Mohan R; Chang JY
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):558-563. PubMed ID: 29680255
[TBL] [Abstract][Full Text] [Related]
73. Treatment of early non-small cell lung cancer, stage IA, by image-guided robotic stereotactic radioablation--CyberKnife.
Brown WT; Wu X; Amendola B; Perman M; Han H; Fayad F; Garcia S; Lewin A; Abitbol A; de la Zerda A; Schwade JG
Cancer J; 2007; 13(2):87-94. PubMed ID: 17476136
[TBL] [Abstract][Full Text] [Related]
74. CyberKnife
Oudin V; Salleron J; Marchesi V; Peiffert D; Khadige M; Faivre JC
J Thorac Dis; 2023 Sep; 15(9):4636-4647. PubMed ID: 37868838
[TBL] [Abstract][Full Text] [Related]
75. Clinical outcome of fiducial-less CyberKnife radiosurgery for stage I non-small cell lung cancer.
Jung IH; Song SY; Jung J; Cho B; Kwak J; Je HU; Choi W; Jung NH; Kim SS; Choi EK
Radiat Oncol J; 2015 Jun; 33(2):89-97. PubMed ID: 26157678
[TBL] [Abstract][Full Text] [Related]
76. CyberKnife Radiosurgery of Skull-base Tumors: A UK Center Experience.
Wilson HP; Price PM; Ashkan K; Edwards A; Green MM; Cross T; Beaney RP; Davies R; Sibtain A; Plowman NP; Goldsmith C
Cureus; 2018 Mar; 10(3):e2380. PubMed ID: 29805949
[TBL] [Abstract][Full Text] [Related]
77. CyberKnife with Tumor Tracking: An Effective Treatment for High-Risk Surgical Patients with Stage I Non-Small Cell Lung Cancer.
Chen VJ; Oermann E; Vahdat S; Rabin J; Suy S; Yu X; Collins SP; Subramaniam D; Banovac F; Anderson E; Collins BT
Front Oncol; 2012; 2():9. PubMed ID: 22655258
[TBL] [Abstract][Full Text] [Related]
78. Cyberknife
Khadige M; Salleron J; Marchesi V; Oldrini G; Peiffert D; Beckendorf V
J Thorac Dis; 2018 Aug; 10(8):4976-4984. PubMed ID: 30233872
[TBL] [Abstract][Full Text] [Related]
79. Endobronchial coil spring fiducial markers for CyberKnife® stereotactic body radiation therapy.
Casutt A; Noirez L; Bernasconi M; Koutsokera A; Beigelman-Aubry C; Kinj R; Ozsahin EM; Durham AD; von Garnier C; Lovis A
Respirology; 2021 May; 26(5):469-476. PubMed ID: 33403786
[TBL] [Abstract][Full Text] [Related]
80. CyberKnife with Tumor Tracking: An Effective Treatment for High-Risk Surgical Patients with Single Peripheral Lung Metastases.
Snider JW; Oermann EK; Chen V; Rabin J; Suy S; Yu X; Vahdat S; Collins SP; Banovac F; Anderson E; Collins BT
Front Oncol; 2012; 2():63. PubMed ID: 22754870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
